Genetically Modified Clostridium Acetobutylicum for Lignocellulosic Biomass
Summary
The USPTO has published a patent application (US20260085278A1) detailing genetically modified Clostridium acetobutylicum strains designed for efficient growth on lignocellulosic biomass. The application, filed by Institut National des Sciences Appliquees de Toulouse, describes overexpressing specific operons to enhance biomass conversion for producing bulk chemicals like ethanol and butanol.
What changed
This document is a USPTO patent application (US20260085278A1) concerning genetically modified Clostridium acetobutylicum strains. The core innovation involves overexpressing the cip-cel operon to improve growth on lignocellulosic biomass, enabling the production of various bulk chemicals such as ethanol, butanol, acetone, and lactic acid. The application was filed by the Institut National des Sciences Appliquees de Toulouse.
As a patent application, this document does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future developments in biotechnology and chemical production. Companies operating in the pharmaceutical, biotechnology, or industrial chemical sectors may wish to monitor the progress of this patent application and related intellectual property, as it could impact future manufacturing processes and product development in areas such as biofuels and bio-based chemicals.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
GENETICALLY MODIFIED LIGNOCELLULOLYTIC CLOSTRIDIUM ACETOBUTYLICUM
Application US20260085278A1 Kind: A1 Mar 26, 2026
Assignee
Institut National des Sciences Appliquees de Toulouse
Inventors
Tom WILDING-STEELE, Quentin RAMETTE, Philippe SOUCAILLE
Abstract
The present invention relates to a genetically modified Clostridium acetobutylicum able to grow on lignocellulosic biomass, in which the cip-cel operon is overexpressed, the expression level of each gene of the cip-cel operon in the genetically modified Clostridium acetobutylicum being higher than its expression level in a corresponding non-genetically modified Clostridium acetobutylicum, as well as derivatives thereof with further modifications increasing growth on lignocellulosic biomass, and the use of these strains for the production of bulk chemicals by conversion of lignocellulose as source of carbon, such as ethanol, butanol, glycerol, 1,2-propanediol, acetone, isopropanol, isobutene, hydrogen, acetic acid and lactic acid and the like.
CPC Classifications
C12N 1/20 C12N 9/2437 C12N 9/2482 C12P 7/06 C12P 7/16 C12P 7/56 C12R 2001/145 C12Y 302/01004 C12Y 302/01008
Filing Date
2023-09-15
Application No.
19110846
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.